Wright Medical Group NV was founded in the 1940s by René Tornier in Saint-Ismier, France. The Company is a medical device company focused on extremities and biologics products. It provides surgical solutions for the upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics markets. The Company has operations located in Memphis, Tennessee (U.S. headquarters, research and development, sales and marketing administration, and administrative activities); Bloomington, Minnesota (upper extremities sales and marketing); Arlington, Tennessee (manufacturing and warehousing operations); Grenoble, France (manufacturing and research and development); and Macroom, Ireland (manufacturing). In addition, it has local sales and distribution offices in Canada, Australia, Asia, and throughout Europe. The Company operates in one segment, orthopaedic products, which includes the design, manufacture, marketing, and sales of extremities and biologics products. It offers product portfolio of over 160 extremities products and 20 biologics products that are designed to provide solutions to its surgeon customers. Its product portfolio consists of Upper extremities, which include joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; Lower extremities, which include joint implants and bone fixation devices for the foot and ankle; Biologics, which include products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth; Sports medicine and other, which include products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries and other ancillary products; and Large joints, which include hip and knee replacement implants. Its sales and marketing efforts are engaged in orthopaedic, trauma, and podiatric surgeons. The Company's sales and distribution system in the United States consisted of 65 geographic sales territories that are staffed by 458 direct sales representatives and 30 independent sales agencies or distributors. Internationally, it sells its full product portfolio, including products for upper and lower extremities, biologics, sports medicine and other, and large joints. Its international sales and distribution system currently consists of 11 direct sales offices and approximately 90 distributors that sell products in over 50 countries. It has subsidiaries with direct sales offices in the United Kingdom, France, Germany, Italy, Denmark, Netherlands, Canada, Japan, and Australia. Its products are sold in other countries in Europe, Asia, Africa, and Latin America using stocking distribution partners. The Company manufactures its internally-sourced products in four locations: Arlington, Tennessee; Montbonnot, France; Grenoble, France; and Macroom, Ireland. It leases the manufacturing facility in Arlington, Tennessee from the Industrial Development Board of the Town of Arlington. The Company's competitors include mid-sized companies in the orthopaedic and biologics industries, as well as academic institutions and other public and private research organizations that continue to conduct research, seek patent protection, and establish arrangements for commercializing products that will compete with the Company's products.
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.